Allergy Relief Fexofenadine Hydrochloride Tablets Recalled for Failed Quality Specifications
CVS Pharmacy is recalling 16,200 cartons of Allergy Relief fexofenadine hydrochloride tablets nationwide due to failed impurities and degradation specifications. Stop using affected lot 2DV1925 and consult a pharmacist.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II drug recall for failed quality specifications. No illnesses or injuries have been reported in the source material. The hazard—impurities and degradation—presents a potential risk to patient health and medication efficacy, but without documented harm, the severity is rated as High rather than Severe.
Plain-English summary
CVS Pharmacy, Inc. is recalling Allergy Relief fexofenadine hydrochloride tablets, 180 mg, 30-count cartons, manufactured by L. Perrigo Company. The tablets were recalled because they failed to meet FDA specifications for impurities and degradation. The affected lot number is 2DV1925 with an expiration date of June 2023.
A total of 16,200 cartons were distributed nationwide throughout the United States.
Consumers who have purchased this product should stop using it immediately. Return the product to the pharmacy where it was purchased or contact CVS Pharmacy for return instructions. Consumers should consult with a healthcare provider regarding alternative allergy relief options if needed.
The recalled product
- Product
- Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg, 30-count cartons, Distributed By: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895. NDC 69842-0914-39
- Manufacturer
- L. Perrigo Company
- Category
- Drug
- Hazard
- impurities
- degradation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 2DV1925
- Exp. date 06/23
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27